메뉴 건너뛰기




Volumn 145, Issue 4, 2006, Pages 310-312

Lipohypertrophy in acromegaly induced by the new growth hormone receptor antagonist pegvisomant [3]

Author keywords

[No Author keywords available]

Indexed keywords

LIVER ENZYME; PEGVISOMANT; SOMATOMEDIN C; DRUG DERIVATIVE; HUMAN GROWTH HORMONE;

EID: 33747100659     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-145-4-200608150-00017     Document Type: Letter
Times cited : (29)

References (5)
  • 3
    • 0036800303 scopus 로고    scopus 로고
    • Growth hormone receptor antagonists: Discovery, development, and use in patients with acromegaly
    • Kopchick JJ, Parkinson C, Stevens EC, Trainer PJ. Growth hormone receptor antagonists: discovery, development, and use in patients with acromegaly. Endocr Rev. 2002;23:623-46.
    • (2002) Endocr Rev , vol.23 , pp. 623-646
    • Kopchick, J.J.1    Parkinson, C.2    Stevens, E.C.3    Trainer, P.J.4
  • 4
    • 0034919001 scopus 로고    scopus 로고
    • Modulation of cortisol metabolism by the growth hormone receptor antagonist pegvisomant in patients with acromegaly
    • Trainer PJ, Drake WM, Perry LA, Taylor NF, Besser GM, Monson JP. Modulation of cortisol metabolism by the growth hormone receptor antagonist pegvisomant in patients with acromegaly. J Clin Endocrinol Metab. 2001;86:2989-92.
    • (2001) J Clin Endocrinol Metab , vol.86 , pp. 2989-2992
    • Trainer, P.J.1    Drake, W.M.2    Perry, L.A.3    Taylor, N.F.4    Besser, G.M.5    Monson, J.P.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.